A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
NCT02700373
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Contact Dermatitis
Interventions
DRUG:
PDC-APB
DRUG:
Placebo
Sponsor
Hapten Sciences, Inc.